Elevated serum uric acid increases incident coronary artery calcification risk in Chinese adults undergoing health checkups - Report - MDSpire

Elevated serum uric acid increases incident coronary artery calcification risk in Chinese adults undergoing health checkups

  • By

  • You You

  • Qixiang Lei

  • Min Ni

  • Ke Ming

  • Yujun Long

  • Yu Lu

  • July 15, 2026

Share

Increased Serum Uric Acid Levels Linked to Higher Risk of Coronary Artery Calcification in Chinese Adults During Health Screenings

Overview

This study investigates the association between serum uric acid levels and the risk of incident coronary artery calcification (CAC) in a Chinese cohort. Findings indicate that higher serum uric acid levels are linked to an increased risk of CAC over a median follow-up of 6 years.

Background

Coronary artery calcification is a predictor of cardiovascular disease and mortality. Understanding the relationship between serum uric acid and CAC is important, given the inconsistent evidence in existing literature. This study explores the role of serum uric acid as a potential risk factor for CAC in a Chinese population.

Data Highlights

MeasureValue
Participants with incident CAC560 (8.0%)
Hazard ratio per SD increase in serum uric acid1.21 (95% CI: 1.09–1.35, P < 0.001)
Hazard ratio for hyperuricemia1.31 (95% CI: 1.08–1.58, P = 0.005)

Key Findings

  • 560 participants developed incident coronary artery calcification during the study.
  • Each standard deviation increase in serum uric acid was associated with a 21% higher risk of incident CAC.
  • Participants with hyperuricemia had a 31% higher risk of CAC compared to those with normal uric acid levels.
  • A linear dose–response relationship was observed between serum uric acid levels and the risk of incident CAC.

Clinical Implications

Monitoring serum uric acid levels may be important in assessing cardiovascular risk in populations undergoing health screenings.

Conclusion

Elevated serum uric acid levels are associated with an increased risk of incident coronary artery calcification.

Related Resources & Content

  1. Frontiers in Cardiovascular Medicine, 2026 -- Elevated Serum Uric Acid Increases Incident Coronary Artery Calcification Risk in Chinese Health-Checkup Adults
  2. Clinical Research in Cardiology — Uric acid and subclinical atherosclerosis: distinct associations across coronary and carotid arteries
  3. conexiant — Serum Urate Goals Tied to Lower CV Risk
  4. BMC Endocrine Disorders — The association between the triglyceride-glucose index and serum uric acid: a systematic review and meta-analysis
  5. Frontiers in Neurology — Serum uric acid-to-HDL cholesterol ratio and stroke prevalence: NHANES 1999–2018 with external support from an imaging-confirmed hemorrhagic stroke dataset
  6. Opportunistic Detection of Coronary Artery Calcium on Non-Cardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association
  7. Guideline-Directed Application of Coronary Artery Calcium Scores for Primary Prevention of Atherosclerotic Cardiovascular Disease
  8. Expanding Coverage of Cardiac Computed Tomography for Calcium Scoring
  9. Association of hyperuricemia with coronary heart disease and other cardiovascular outcomes: A systematic review and dose-response meta-analysis - PubMed
  10. Relation of serum uric acid with the risk of coronary heart disease: an updated systematic review and dose-response meta-analysis of epidemiologic studies - PubMed
  11. Uric Acid Levels and Cardiovascular and Cerebrovascular Diseases: A Mendelian Randomization Study - PubMed
  12. Causal relationship between serum uric acid and cardiovascular disease: A Mendelian randomization study - PMC
  13. Frontiers | Elevated Serum Uric Acid Increases Incident Coronary Artery Calcification Risk in Chinese Health-Checkup Adults
  14. Allopurinol and Cardiovascular Outcomes in Patients With Ischemic Heart Disease - American College of Cardiology
  15. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout | New England Journal of Medicine
  16. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial - PubMed
  17. Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2025 update - PubMed
  18. 2024 Update of Chinese Guidelines for Diagnosis and Treatment of Hyperuricemia and Gout Part I: Recommendations for General Patients - PubMed

Original Source(s)

Related Content